Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 18 results:
Author [ Title] Type Year Filters: Author is Matthews, David R [Clear All Filters]
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes..
Ann Intern Med. 174(1), 141.
(2021). Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis..
Ann Intern Med. 173(4), 278-286.
(2020).
(2021).
(2021).
(2012).
Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis..
Diabetes Obes Metab. 25(10), 3020-3029.
(2023). GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis..
Diabetes Res Clin Pract. 174, 108737.
(2021). Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes..
Diabetologia. 58(3), 429-42.
(2015). Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes..
Diabetes Care. 38(1), 140-9.
(2015). Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis..
Diabetologia. 65(8), 1251-1261.
(2022). Methodology for quantifying fasting glucose homeostasis in type 2 diabetes: observed variability and lability..
J Diabetes Sci Technol. 7(3), 640-5.
(2013). Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis..
Expert Opin Pharmacother. 18(9), 843-851.
(2017). Semaglutide for type 2 diabetes mellitus: a systematic review and meta-analysis.
Diabetes, Obesity and Metabolism.
(2018). Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis..
Diabetes Obes Metab. 20(9), 2255-2263.
(2018). Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis..
Ann Intern Med. 159(4), 262-74.
(2013). Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis..
Diabetes Obes Metab. 24(1), 106-114.
(2022). Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis..
Diabetes Obes Metab. 23(10), 2395-2401.
(2021). Using N-of-1 trials in evidence-based clinical practice..
JAMA. 301(10), 1022-3; author reply 1023.
(2009).